MLEC (Moolec Science) Debt-to-Equity : 3.88 (As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Moolec Science Debt-to-Equity?

Moolec Science's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $3.65 Mil. Moolec Science's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $18.43 Mil. Moolec Science's Total Stockholders Equity for the quarter that ended in Sep. 2024 was $5.69 Mil. Moolec Science's debt to equity for the quarter that ended in Sep. 2024 was 3.88.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Moolec Science's Debt-to-Equity or its related term are showing as below:

MLEC' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.78 Max: 3.88
Current: 3.88

During the past 4 years, the highest Debt-to-Equity Ratio of Moolec Science was 3.88. The lowest was 0.01. And the median was 0.78.

MLEC's Debt-to-Equity is ranked worse than
97.44% of 1014 companies
in the Biotechnology industry
Industry Median: 0.14 vs MLEC: 3.88

Moolec Science Debt-to-Equity Historical Data

The historical data trend for Moolec Science's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moolec Science Debt-to-Equity Chart

Moolec Science Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

Debt-to-Equity

0.26

2.15

Moolec Science Quarterly Data
	Jun21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Equity	Get a 7-Day Free Trial							0.31	1.25	2.09	2.15	3.88

Competitive Comparison of Moolec Science's Debt-to-Equity

For the Biotechnology subindustry, Moolec Science's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Moolec Science's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Moolec Science's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Moolec Science's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

Moolec Science Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Moolec Science's Debt to Equity Ratio for the fiscal year that ended in Jun. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.729	+	11.952)	/	6.816
	=	2.15

Moolec Science's Debt to Equity Ratio for the quarter that ended in Sep. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(3.652	+	18.432)	/	5.693
	=	3.88

Moolec Science (NAS:MLEC) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Moolec Science Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Moolec Science's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Moolec Science Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moolec Science SA (NAS:MLEC) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

17, Boulevard F.W. Raiffeisen, Luxembourg, LUX, L-2411

Website

https://www.moolecscience.com

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.